Publications by authors named "Nicholas Hellmann"

Claim this Profile
R
Reframing HIV care: putting people at the centre of antiretroviral delivery.
Chris Duncombe, Scott Rosenblum, Nicholas Hellmann, Charles Holmes, Lynne Wilkinson

Trop Med Int Health· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asking the right questions: developing evidence-based strategies for treating HIV in women and children.
Quarraisha Abdool Karim, Anchilla Banegura, Pedro Cahn, Celia D C Christie, Robert Dintruff, Nicholas Hellmann

BMC Public Health· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics.
Julia E Aledort, Allan Ronald, Sylvie M Le Blancq, Renee Ridzon, Alan Landay, Nicholas Hellmann

Nature· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics.
Julia E Aledort, Allan Ronald, Maria E Rafael, Federico Girosi, Peter Vickerman, Nicholas Hellmann

Nature· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 pol replication capacity predicts disease progression.
Eric S Daar, Karen L Kesler, Terri Wrin, Christos J Petropoulo, Michael Bates, Nicholas S Hellmann

AIDS· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.
Richard H Haubrich, Carol A Kemper, Nicholas S Hellmann, Philip H Keiser, Mallory D Witt

AIDS· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance.
Susan S Kaplan, Guido Ferrari, Terri Wrin, Nicholas S Hellmann, Georgia D Tomaras

AIDS Res Hum Retroviruses· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdine.
Erik J Uhlmann, Pablo Tebas, Gregory A Storch, William G Powderly, Yolanda S Lie, Nicholas S Hellmann

J Clin Virol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects.
Ronald Swanstrom, Ronald J Bosch, David Katzenstein, Hailong Cheng, Hongyu Jiang, Nicholas Hellmann

J Infect Dis· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.
Lisa M Demeter, Heather J Ribaudo, Alejo Erice, Susan H Eshleman, Scott M Hammer, Nicholas S Hellmann

Clin Infect Dis· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of antiretroviral drug resistance in the United States.
Douglas D Richman, Sally C Morton, Terri Wrin, Nicholas Hellmann, Sandra Berry

AIDS· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.
Jason D Barbour, Frederick M Hecht, Terri Wrin, Mark R Segal, Clarissa A Ramstead, Nicholas S Hellmann

J Infect Dis· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection.
Andrew J Leigh Brown, Simon D W Frost, Benjamin Good, Eric S Daar, Viviana Simon, Nicholas S Hellmann

J Virol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus.
Rajesh T Gandhi, Alysse Wurcel, Eric S Rosenberg, Mary N Johnston, Nicholas Hellmann

Clin Infect Dis· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance.
Joel E Gallant, Peter Z Gerondelis, Mark A Wainberg, Nancy S Shulman, Richard H Haubrich, Nicholas S Hellmann

Antivir Ther· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of cutpoints for phenotypic hypersusceptibility to efavirenz.
Ronald J Bosch, Gerald F Downey, David A Katzenstein, Nicholas Hellmann, Lee Bacheler

AIDS· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.
Jeannette M Whitcomb, Neil T Parkin, Colombe Chappey, Nicholas S Hellmann, Christos J Petropoulos

J Infect Dis· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations.
Stephen Taylor, Patricia Cane, Stéphane Hué, Li Xu, Terri Wrin, Nicholas Hellmann

AIDS Res Hum Retroviruses· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic susceptibility and virological outcome in nucleoside-experienced patients receiving three or four antiretroviral drugs.
David A Katzenstein, Ronald J Bosch, Nicholas Hellmann, Nan Wang, Lee Bacheler

AIDS· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control.
Susan A Sufka, Guido Ferrari, Victoria E Gryszowka, Terri Wrin, Susan A Fiscus, Nicholas S Hellmann

J Infect Dis· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.
Andrew J Leigh Brown, Simon D W Frost, W Christopher Mathews, Keith Dawson, Nicholas S Hellmann

J Infect Dis· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical applications of viral fitness in clinical practice.
Michael Bates, Terri Wrin, Wei Huang, Christos Petropoulos, Nicholas Hellmann

Curr Opin Infect Dis· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates.
Jeannette M Whitcomb, Wei Huang, Kay Limoli, Ellen Paxinos, Terri Wrin, Nicholas S Hellmann

AIDS· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients.
Nancy S Shulman, Michael D Hughes, Mark A Winters, Robert W Shafer, Andrew R Zolopa, Nicholas S Hellmann

J Acquir Immune Defic Syndr· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic and genotypic HIV-1 drug resistance assays provide complementary information.
Neil Parkin, Colombe Chappey, Laura Maroldo, Michael Bates, Nicholas S Hellmann

J Acquir Immune Defic Syndr· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis